OPKO Health, Inc.
LSE: 0KCS.L0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- London Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Phillip Frost
- Employees
- 2,997
- Headquarters
- Miami, United States
- IPO year
- 2018
- Market cap
- $854.2M
- Website
- https://www.opko.com
Loading 0KCS…
Loading profile data…Frequently asked questions about 0KCS
What does OPKO Health, Inc. (0KCS.L) do?
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and...
Where does 0KCS.L trade?
OPKO Health, Inc. (0KCS.L) trades on the London Stock Exchange.
What sector is 0KCS.L in?
OPKO Health, Inc. (0KCS.L) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of OPKO Health, Inc.?
Phillip Frost is the chief executive officer of OPKO Health, Inc. (0KCS.L).
Where is OPKO Health, Inc. headquartered?
OPKO Health, Inc. is headquartered in United States.
Does 0KCS.L pay a dividend?
OPKO Health, Inc. (0KCS.L) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 0KCS.L go public?
OPKO Health, Inc. (0KCS.L) completed its initial public offering in 2018.